Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense
Trypanosoma brucei rhodesiense is one of the causative agents of human sleeping sickness, a fatal disease that is transmitted by tsetse flies and restricted to Sub-Saharan Africa. Here we investigate two independent lines of T. b. rhodesiense that have been selected with the drugs melarsoprol and pentamidine over the course of 2 years, until they exhibited stable cross-resistance to an unprecedented degree. We apply comparative genomics and transcriptomics to identify the underlying mutations. Only few mutations have become fixed during selection. Three genes were affected by mutations in both lines: the aminopurine transporter AT1, the aquaporin AQP2, and the RNA-binding protein UBP1. The melarsoprol-selected line carried a large deletion including the adenosine transporter gene AT1, whereas the pentamidine-selected line carried a heterozygous point mutation in AT1, G430R, which rendered the transporter non-functional. Both resistant lines had lost AQP2, and both lines carried the same point mutation, R131L, in the RNA-binding motif of UBP1. The finding that concomitant deletion of the known resistance genes AT1 and AQP2 in T. b. brucei failed to phenocopy the high levels of resistance of the T. b. rhodesiense mutants indicated a possible role of UBP1 in melarsoprol-pentamidine cross-resistance. However, homozygous in situ expression of UBP1-Leu(131) in T. b. brucei did not affect the sensitivity to melarsoprol or pentamidine.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
---|---|
Enthalten in: |
Cellular and molecular life sciences : CMLS - 73(2016), 17 vom: 10. Sept., Seite 3387-400 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Graf, Fabrice E [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 23.08.2017 Date Revised 13.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s00018-016-2173-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM258385669 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM258385669 | ||
003 | DE-627 | ||
005 | 20240213232114.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00018-016-2173-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1290.xml |
035 | |a (DE-627)NLM258385669 | ||
035 | |a (NLM)26973180 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Graf, Fabrice E |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.08.2017 | ||
500 | |a Date Revised 13.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Trypanosoma brucei rhodesiense is one of the causative agents of human sleeping sickness, a fatal disease that is transmitted by tsetse flies and restricted to Sub-Saharan Africa. Here we investigate two independent lines of T. b. rhodesiense that have been selected with the drugs melarsoprol and pentamidine over the course of 2 years, until they exhibited stable cross-resistance to an unprecedented degree. We apply comparative genomics and transcriptomics to identify the underlying mutations. Only few mutations have become fixed during selection. Three genes were affected by mutations in both lines: the aminopurine transporter AT1, the aquaporin AQP2, and the RNA-binding protein UBP1. The melarsoprol-selected line carried a large deletion including the adenosine transporter gene AT1, whereas the pentamidine-selected line carried a heterozygous point mutation in AT1, G430R, which rendered the transporter non-functional. Both resistant lines had lost AQP2, and both lines carried the same point mutation, R131L, in the RNA-binding motif of UBP1. The finding that concomitant deletion of the known resistance genes AT1 and AQP2 in T. b. brucei failed to phenocopy the high levels of resistance of the T. b. rhodesiense mutants indicated a possible role of UBP1 in melarsoprol-pentamidine cross-resistance. However, homozygous in situ expression of UBP1-Leu(131) in T. b. brucei did not affect the sensitivity to melarsoprol or pentamidine | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a African trypanosomes | |
650 | 4 | |a Aquaporin | |
650 | 4 | |a Melarsoprol | |
650 | 4 | |a Pentamidine | |
650 | 4 | |a Purine permease | |
650 | 4 | |a RNA-binding protein | |
650 | 7 | |a Aquaporins |2 NLM | |
650 | 7 | |a DNA, Protozoan |2 NLM | |
650 | 7 | |a Nucleoside Transport Proteins |2 NLM | |
650 | 7 | |a Protozoan Proteins |2 NLM | |
650 | 7 | |a RNA-Binding Proteins |2 NLM | |
650 | 7 | |a Trypanocidal Agents |2 NLM | |
650 | 7 | |a Pentamidine |2 NLM | |
650 | 7 | |a 673LC5J4LQ |2 NLM | |
650 | 7 | |a Melarsoprol |2 NLM | |
650 | 7 | |a ZF3786Q2E8 |2 NLM | |
700 | 1 | |a Ludin, Philipp |e verfasserin |4 aut | |
700 | 1 | |a Arquint, Christian |e verfasserin |4 aut | |
700 | 1 | |a Schmidt, Remo S |e verfasserin |4 aut | |
700 | 1 | |a Schaub, Nadia |e verfasserin |4 aut | |
700 | 1 | |a Kunz Renggli, Christina |e verfasserin |4 aut | |
700 | 1 | |a Munday, Jane C |e verfasserin |4 aut | |
700 | 1 | |a Krezdorn, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Baker, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Horn, David |e verfasserin |4 aut | |
700 | 1 | |a Balmer, Oliver |e verfasserin |4 aut | |
700 | 1 | |a Caccone, Adalgisa |e verfasserin |4 aut | |
700 | 1 | |a de Koning, Harry P |e verfasserin |4 aut | |
700 | 1 | |a Mäser, Pascal |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cellular and molecular life sciences : CMLS |d 1997 |g 73(2016), 17 vom: 10. Sept., Seite 3387-400 |w (DE-627)NLM090610393 |x 1420-9071 |7 nnns |
773 | 1 | 8 | |g volume:73 |g year:2016 |g number:17 |g day:10 |g month:09 |g pages:3387-400 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00018-016-2173-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 73 |j 2016 |e 17 |b 10 |c 09 |h 3387-400 |